TMEM213 and lung adenocarcinoma: TMEM213 has been shown to be downregulated in clear cell renal cell carcinoma with a predicted association with invasion and metastasis [82], whereas it is upregulated in lung adenocarcinoma and contributes to a longer survival of patients [83].